SANGITA BASNET: Open Payments
NPI 1053193193 · FREDERICK, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$850 in 35 payments from 15 companies in 2025. Trend: 2023 $55 · 2024 $712 · 2025 $850
Food & beverage: $850
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $271 |
| GlaxoSmithKline, LLC. | 6 | $133 |
| ABBVIE INC. | 4 | $78 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $46 |
| HARMONY BIOSCIENCES LLC | 1 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Exact Sciences Corporation | 1 | $26 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
Products named: Ozempic, TRELEGY ELLIPTA, Wegovy, CAPLYTA, AIRSUPRA, VRAYLAR, WAKIX, FARXIGA.
Industry payments across MD — which companies pay providers there.
